Royce & Associates’s Paysign PAYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.05M Sell
616,365
-161,818
-21% -$1.07M 0.04% 501
2026
Q1
$4.59M Hold
778,183
0.05% 480
2025
Q4
$4.01M Buy
778,183
+155,606
+25% +$839K 0.04% 498
2025
Q3
$3.92M Buy
622,577
+373,519
+150% +$2.39M 0.04% 504
2025
Q2
$1.79M Buy
249,058
+229,739
+1,189% +$823K 0.02% 613
2025
Q1
$41K Buy
19,319
+5,166
+37% +$13.8K ﹤0.01% 792
2024
Q4
$42.7K Sell
14,153
-207,558
-94% -$728K ﹤0.01% 826
2024
Q3
$814K Buy
+221,711
New +$1.01M 0.01% 750
2023
Q4
Sell
-17,545
Closed -$34.2K 921
2023
Q3
$34.2K Buy
17,545
+1,169
+7% +$2.41K ﹤0.01% 906
2023
Q2
$40.1K Buy
+16,376
New +$50.4K ﹤0.01% 909

Other funds holding PAYS

Royce & Associates's PAYS Position: Q2 2026 in Review

Royce & Associates reduced its Paysign (PAYS) stake by 21% in Q2 2026, selling an estimated $1.07M and leaving 616,365 shares worth $5.05M. The position accounts for 0.04% of the portfolio, ranked #501.

Royce & Associates first reported a position in PAYS in Q2 2023 and has held it in 10 quarters since. 132 funds tracked by Wall St. Rank hold PAYS as of Q2 2026.

  • Royce & Associates held 616,365 shares of Paysign worth $5.05M as of Q2 2026.
  • Royce & Associates sold 161,818 Paysign shares in Q2 2026, an estimated $1.07M.
  • Paysign made up 0.04% of Royce & Associates's portfolio in Q2 2026, its #501 holding.
  • Royce & Associates first reported a position in Paysign in Q2 2023 and has held it in 10 quarters since.
  • 132 funds tracked by Wall St. Rank held Paysign as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.